Literature DB >> 22444643

A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays.

Anna I Astashkina1, Brenda K Mann, Glenn D Prestwich, David W Grainger.   

Abstract

Cell-cell and cell-matrix interactions control cell phenotypes and functions in vivo. Maintaining these interactions in vitro is essential to both produce and retain cultured cell fidelity to normal phenotype and function in the context of drug efficacy and toxicity screening. Two-dimensional (2-D) cultures on culture plastics rarely recapitulate any of these desired conditions. Three dimensional (3-D) culture systems provide a critical junction between traditional, yet often irrelevant, in vitro cell cultures and more accurate, yet costly, in vivo models. This study describes development of an organoid-derived 3-D culture of kidney proximal tubules (PTs) that maintains native cellular interactions in tissue context, regulating phenotypic stability of primary cells in vitro for up to 6 weeks. Furthermore, unlike immortalized cells on plastic, these 3-D organoid kidney cultures provide a more physiologically-relevant response to nephrotoxic agent exposure, with production of toxicity biomarkers found in vivo. This biomimetic primary kidney model has broad applicability to high-throughput drug and biomarker nephrotoxicity screening, as well as more mechanistic drug toxicology, pharmacology, and metabolism studies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22444643     DOI: 10.1016/j.biomaterials.2012.02.063

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  25 in total

1.  An in vitro method for nephrotoxicity evaluation using HK-2 human kidney epithelial cells combined with biomarkers of nephrotoxicity.

Authors:  Xuan Qiu; Xiaobing Zhou; Yufa Miao; Bo Li
Journal:  Toxicol Res (Camb)       Date:  2018-08-13       Impact factor: 3.524

Review 2.  Organ-on-a-chip engineering: Toward bridging the gap between lab and industry.

Authors:  Qasem Ramadan; Mohammed Zourob
Journal:  Biomicrofluidics       Date:  2020-07-14       Impact factor: 2.800

Review 3.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

Review 4.  Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.

Authors:  Ki-Hwan Nam; Alec S T Smith; Saifullah Lone; Sunghoon Kwon; Deok-Ho Kim
Journal:  J Lab Autom       Date:  2014-11-10

5.  Synthetic alternatives to Matrigel.

Authors:  Elizabeth A Aisenbrey; William L Murphy
Journal:  Nat Rev Mater       Date:  2020-05-27       Impact factor: 66.308

Review 6.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

7.  High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping.

Authors:  Stefan M Czerniecki; Nelly M Cruz; Jennifer L Harder; Rajasree Menon; James Annis; Edgar A Otto; Ramila E Gulieva; Laura V Islas; Yong Kyun Kim; Linh M Tran; Timothy J Martins; Jeffrey W Pippin; Hongxia Fu; Matthias Kretzler; Stuart J Shankland; Jonathan Himmelfarb; Randall T Moon; Neal Paragas; Benjamin S Freedman
Journal:  Cell Stem Cell       Date:  2018-05-17       Impact factor: 24.633

8.  A human in vitro model that mimics the renal proximal tubule.

Authors:  Anke Hoppensack; Christian C Kazanecki; David Colter; Anna Gosiewska; Johanna Schanz; Heike Walles; Katja Schenke-Layland
Journal:  Tissue Eng Part C Methods       Date:  2014-01-03       Impact factor: 3.056

9.  A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.

Authors:  Melanie Adler; Susanne Ramm; Marc Hafner; Jeremy L Muhlich; Esther Maria Gottwald; Elijah Weber; Alenka Jaklic; Amrendra Kumar Ajay; Daniel Svoboda; Scott Auerbach; Edward J Kelly; Jonathan Himmelfarb; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2015-08-10       Impact factor: 10.121

Review 10.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.